Tiny Gem Archives - Page 9 of 63

WednesdayNov 19, 2025 10:00 am

Study identifies Biomarker to Predict Success of Immunotherapy, Chemo for Breast Cancer

Researchers from the University of Illinois Urbana-Champaign have discovered a protein that can predict which breast cancer patients will respond well to chemotherapy and immunotherapy. After conducting genome-wide screening in human cancer cells, the research team found that the FGD3 protein was a promising biomarker in determining chemotherapy and immunotherapy efficacy. Patients with high FGD3 levels responded favorably to treatment across all breast cancer types, while those with low levels show poor responses, Professor of biochemistry David J. Shapiro notes. The findings build on 2021 research when the team developed ErSO, an experimental drug that killed 100 percent of breast…

MondayNov 17, 2025 10:00 am

EV Sales in China Set New Record in October

Data from the China Association of Automobile Manufacturers (CAAM) has revealed that China sold 1.7 million electric and plug-in hybrid vehicles in October, setting a new monthly record for the rapidly expanding electric vehicle market. EV makers like BYD and Nio surpassed September sales by roughly 111,000 units, with year-over-year growth hitting 20 percent compared to October 2024. The figure includes exports, which totaled 256,000 vehicles, leaving about 1.5 million for the domestic market. Most of the growth was spurred by increased battery-electric vehicle (BEV) sales. Pure electric sales reached 1.1 million units, up 32% from last year, outpacing the…

FridayNov 14, 2025 9:45 am

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Targets Glioblastoma with Innovative Therapies, Addressing One of Oncology’s Greatest Unmet Needs

Glioblastoma multiforme (“GBM”) is an aggressive brain cancer with limited treatment options, and CEO John Climaco emphasized the company’s commitment to overcoming the blood-brain barrier, a key obstacle in brain cancer therapy. Lead candidate TPI 287, an abeotaxane, has shown early evidence of appearing to cross the blood-brain barrier and producing clinical responses. Phase 2 planning is underway following encouraging data from a Phase 1 combination study with bevacizumab (Avastin). The company’s repurposed global clinical network and regulatory progress position it for potential late-stage development in 2026. TPI 287 holds multiple Orphan Drug Designations, covering gliomas, neuroblastoma, and other CNS-related…

WednesdayNov 12, 2025 10:00 am

UK Government Announces $18.4M in Awards to Support Quantum Computing Projects

British officials have allocated $18.4 million in awards to support over a dozen quantum computing projects. The Quantum Sensing Mission Primer awards' goal is quite ambitious: deploy quantum computers that surpass current supercomputers by 2036. Science minister Patrick Vallance called the technology revolutionary, noting that it could transform medical diagnostics and slash computation times from decades to seconds. Cumulatively, the UK has pledged $880 million to advance quantum technology development in the country. Innovate UK will fund practical applications in medicine and infrastructure across 14 projects. One team is building a handheld eye scanner to replace the room-sized machines hospitals…

MondayNov 10, 2025 10:00 am

New Implants Defy Necessity of Brain Surgery Against Cancer

Microscopic wireless electronics that self-navigate to diseased brain tissue could eliminate the need for surgery when treating tumors and neurological conditions. Massachusetts Institute of Technology researchers demonstrated the technology in mice, showing how tiny devices injected into the bloodstream can autonomously locate target regions and deliver electrical stimulation without human guidance. These implants are fused with immune cells before injection, allowing them to slip past the body's defenses and cross the blood-brain barrier intact. Each device measures roughly one-billionth of a rice grain's length, built from layered organic semiconducting polymers positioned between metallic components to create an electronic structure. Scientists…

WednesdayNov 05, 2025 10:00 am

Cancer Immunotherapy Could Be Transformed by Boosting Natural Killer Cells

Researchers at MIT and Harvard Medical School have developed a method to enhance natural killer cells that could transform cancer immunotherapy. The team engineered chimeric antigen receptor natural killer cells with modifications that prevent immune system rejection and improve their ability to destroy tumors. Early experiments in mice and laboratory human tissue show the enhanced cells are effective at fighting cancer and well tolerated, offering a promising foundation for next-generation treatments. Natural killer cells function as the body's first defense against virus-infected or cancerous tissue. They react immediately to suspect cells without requiring activation or priming. Chimeric antigen receptors engineered…

MondayNov 03, 2025 10:00 am

China Moves to End Subsidies to its EV Industry

Beijing has removed electric vehicles from its list of strategic emerging industries for the first time in over a decade, signaling a fundamental shift in how the world's largest automotive market will support its dominant EV sector. The exclusion of NEVs from China's 2026-2030 five-year development plan indicates policymakers believe the industry has matured enough to compete without tens of billions’ worth of government subsidies and customer incentives. Market forces rather than policy directives will now determine which manufacturers survive China's increasingly competitive EV market. Data from Jato Dynamics research shows that 93 of the 169 automakers currently operating in…

WednesdayOct 29, 2025 9:00 am

AMD Shares Jump as IBM Says its Existing Chips Can Correct Quantum Computing Errors

AMD shares surged by nearly 8% on Friday after IBM announced that standard AMD chips can run a critical quantum computing error correction algorithm. Investors' response to the breakthrough in qubit technology advancement caused IBM stock to climb approximately 8% as well, heading toward its best single-day performance since January. A recent report revealed that IBM can successfully operate error correction algorithms in real time on AMD's field programmable gate array chips, marking significant progress toward building commercially viable quantum computers. The development addresses one of quantum computing's most persistent challenges: managing the errors that plague qubit-based systems that can…

MondayOct 27, 2025 10:00 am

Scientists Uncover Possible Driver of ‘Chemo Brain’

A recent study has found that the cognitive difficulties which cancer patients experience during and after treatment could stem from chemotherapy-induced damage to the brain's waste drainage network. Newly discovered evidence sheds light on a widespread yet poorly understood phenomenon that affects up to 75% of individuals undergoing cancer therapy, chemo brain. The symptoms associated with this condition, including memory lapses and problems with concentration and finding words, typically persist long after treatment is complete. Published in the journal Communications Biology, the study examined how common cancer drugs impact meningeal lymphatics, specialized vessels within the brain membranes responsible for waste…

WednesdayOct 22, 2025 10:00 am

Study Suggests mRNA Covid Vaccine Could Boost Cancer Immunotherapy

New research published at the European Society for Medical Oncology conference on Sunday has revealed that the mRNA coronavirus vaccine could have an unintended benefit: boosting immunotherapy effectiveness. Although the research is still in its initial phases, experts say Covid vaccines may be able to improve immune function during immunotherapy and make the treatment more potent. Immunotherapy is a relatively new cancer treatment that uses a patient's immune system to fight tumor cells, avoiding the side effects typically associated with chemotherapy and radiation. The connection between coronavirus vaccines and improved immunotherapy efficacy will be explored further in a Phase 3…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

Category: Tiny Gem